(Q28175861)

English

Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

scientific article (publication date: March 2001)

In more languages

Statements

scholarly article

0 references

1 reference

based on heuristic

inferred from title

Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

P S Sanmuganathan

1

0 references

P Ghahramani

2

0 references

P R Jackson

3

0 references

E J Wallis

4

0 references

L E Ramsay

5

0 references

language of work or name

0 references

publication date

March 2001

0 references

0 references

85

0 references

3

0 references

265-71

0 references

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

7 April 2017

Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

29 September 2017

Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

29 September 2017

British Hypertension Society guidelines for hypertension management 1999: summary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

29 September 2017

Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

29 September 2017

Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

29 September 2017

Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

29 September 2017

Randomised trial of prophylactic daily aspirin in British male doctors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

29 September 2017

Confidence intervals for the number needed to treat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

2 June 2018

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

2 June 2018

Prophylactic aspirin and risk of peptic ulcer bleeding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

2 June 2018

Cardiovascular disease risk profiles.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729640

2 June 2018

Risk of major gastrointestinal bleeding with aspirin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11179262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/11179262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/11179262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/11179262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualizing aspirin therapy for prevention of cardiovascular events

1 reference

https://pubmed.ncbi.nlm.nih.gov/11179262

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HEART.85.3.265

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28175861&oldid=1630161598"